If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.295    0.00 (0.00%)
Bid:
0.29
Ask:
0.30
Spread: 0.01 (3.448%)
Market Cap: £22.94m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Next Phase with Viritech

21 Mar 2022 07:00

RNS Number : 3267F
Haydale Graphene Industries PLC
21 March 2022
 

REACH

For immediate release

21 March 2022

Haydale Graphene Industries plc

 

('Haydale' or the 'Group')

 

Haydale and Viritech Continue to Work Together on the Future of Hydrogen PowerUsing Nanomaterials

 

Building on the Memorandum of Understanding (MOU) signed with Viritech Limited ("Viritech") in September 2021, Haydale, (AIM: HAYD), the global advanced materials group, is pleased to announce the next phase with the cleantech engineering company to develop nano-enhanced epoxy resins for hydrogen storage vessels. The £97,750 Storage of Hydrogen and Nanomaterial Enhancement ('SHYNE') project will run for an initial period of seven months, starting in March.

 

Haydale will focus on the design and development of new materials and resins based on functionalised graphene using its patented HDPlas technology intended for use in Type V hydrogen storage tanks. The resin can act as a permeation barrier for the storage vessel, but the functionalised graphene also potentially offers greatly enhanced mechanical properties including impact and interlaminar sheer to improve the overall performance of the vessel.

The Type V design aims to deliver further weight savings for applications in hyper car and heavy goods road vehicles. The seven-month SHYNE project will focus on advanced materials technology and methodology with the aim of bringing nano-enhanced epoxy into the hydrogen storage market.

Keith Broadbent, Haydale CEO, said: "We are delighted to continue our work with Viritech and, together, be leading the way with ground-breaking hydrogen pressure vessel designs. The use of graphene-enhanced materials offers great weight saving properties and through functionalisation and advanced materials technology their use in automotive and aerospace applications is expected to speed up exponentially through this programme of work."

- Ends -

For further information:

Haydale Graphene Industries plc

Keith Broadbent, CEO Tel: +44 (0) 1269 842946

Sarah Thomas, Marketing Manager Tel: +44 (0) 1269 507026

 

finnCap (Nominated Adviser & Broker)

Julian Blunt / Edward Whiley, Corporate Finance Tel: +44 (0) 20 7220 0500

Andrew Burdis, ECM

 

Notes to Editors

 

Haydale is a global technologies and materials group that facilitates the integration of graphene and other nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale can deliver improvements in electrical, thermal, and mechanical properties, as well as toughness through its state-of-the-art functionalisation. Haydale has granted patents for its technologies in Europe, USA, Australia, Japan, and China and operates from five sites in the UK, USA, and the Far East.

 

For more information please visit: www.haydale.com

 

LinkedIn: Haydale-ltdTwitter: @haydalegraphene

 

About Viritech Limited

 

Viritech is a cleantech engineering company, based at the Horiba-MIRA automotive R&D facility in Nuneaton, with a mission to become the world's leading developer of hydrogen powertrain solutions for the automotive, aerospace, marine & distributed power industries. For more information please visit: www.viritech.co.uk

About Reach announcements 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not a Reach.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAZVLFFLXLEBBK
Date   Source Headline
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results
22nd Nov 20245:27 pmRNSHolding(s) in Company
21st Nov 202411:48 amRNSDirectorate Change
15th Nov 20242:06 pmRNSHolding(s) in Company
14th Nov 20242:45 pmRNSHolding(s) in Company
13th Nov 20242:10 pmRNSResult of General Meeting and TVR
28th Oct 20245:12 pmRNSResult of Retail Offer
28th Oct 20247:00 amRNSResult of Fundraising
25th Oct 20242:20 pmRNSRetail Offer
25th Oct 20242:15 pmRNSProposed Fundraise to raise up to £3.5 million
9th Jul 20247:00 amRNSNew Agreement Worth US$4.0 million
20th May 20247:00 amRNSTrading Update
2nd May 20247:00 amRNSGrant of Share Options and PDMR Dealing
12th Mar 20247:00 amRNSInterim Results
26th Jan 20247:00 amRNSGrant of Options & Surrender of Existing Options
22nd Jan 20247:00 amRNSHaydale selected for Innovate UK Scaleup Programme
7th Dec 202311:36 amRNSResult of AGM
7th Dec 202311:34 amRNSDirectorate Change
6th Dec 20237:00 amRNSHaydale awarded SMART funding
16th Nov 20232:31 pmRNSHolding(s) in Company
13th Nov 20237:00 amRNSPosting of Annual Report & Notice of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSFinal Results
9th Oct 20238:23 amRNSHolding(s) in Company
5th Oct 20231:43 pmRNSDirector/PDMR Shareholding & Total Voting Rights
4th Oct 20234:46 pmRNSHolding(s) in Company
3rd Oct 20233:48 pmRNSResult of General Meeting
2nd Oct 20237:00 amRNSTotal Voting Rights
22nd Sep 20234:30 pmRNSResult of Retail Offer and Total Voting Rights
15th Sep 20236:12 pmRNSResult of Fundraising
15th Sep 20234:00 pmRNSLaunch of Retail Offer
15th Sep 20233:00 pmRNSProposed Placing, Subscription & Retail Offer
15th Sep 20237:00 amRNSWarrant Expiry, Block Admission Cancellation & TVR
22nd Aug 20237:00 amRNSCollaboration with PETRONAS
4th Aug 20231:02 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSDirectorate Change
24th Jul 20237:00 amRNSContract Award
13th Jul 20237:00 amRNSHaydale Delivers LPHW Prototype for Cadent
21st Jun 20237:00 amRNSTrading Update
5th Jun 20237:00 amRNSDirectorate Change
24th May 20237:00 amRNSHaydale to Contribute to the Development of FCHEVs
3rd May 20237:00 amRNSSMART Innovation to Accelerate Graphene Products
26th Apr 20233:06 pmRNSGrant of Share Options
12th Apr 20237:00 amRNSHaydale and Saint-Gobain Collaborate on hBN
16th Mar 20237:00 amRNSHaydale and City Energy Develop UFH with Plumbase
14th Mar 20238:15 amRNSBlock listing Interim Review
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
10th Mar 20237:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.